Libra Infusions Limited (DSE: LIBRAINFU)
Bangladesh
· Delayed Price · Currency is BDT 839.40
-10.90 (-1.28%)
At close: Nov 14, 2024
Libra Infusions Income Statement
Financials in millions BDT. Fiscal year is July - June.
Millions BDT. Fiscal year is Jul - Jun.
Fiscal Year | TTM | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 | 2014 - 2010 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '19 Jun 30, 2019 | Jun '19 Jun 30, 2019 | Jun '18 Jun 30, 2018 | Jun '17 Jun 30, 2017 | Jun '16 Jun 30, 2016 | Jun '15 Jun 30, 2015 | 2014 - 2010 |
| Revenue | 197.03 | 197.03 | 190.72 | 244.26 | 238.15 | 287 | Upgrade
|
| Revenue Growth (YoY) | -19.64% | 3.31% | -21.92% | 2.57% | -17.02% | 1.66% | Upgrade
|
| Cost of Revenue | 119.14 | 119.14 | 113.65 | 161.93 | 158.09 | 175.5 | Upgrade
|
| Gross Profit | 77.89 | 77.89 | 77.07 | 82.33 | 80.05 | 111.51 | Upgrade
|
| Selling, General & Admin | 55.67 | 55.67 | 60.85 | 62.83 | 57.12 | 59.04 | Upgrade
|
| Other Operating Expenses | - | - | - | 0.25 | 0.35 | 0.32 | Upgrade
|
| Operating Expenses | 55.67 | 55.67 | 60.85 | 63.08 | 57.47 | 59.36 | Upgrade
|
| Operating Income | 22.22 | 22.22 | 16.22 | 19.25 | 22.59 | 52.14 | Upgrade
|
| Interest Expense | -22.91 | -22.91 | -8.58 | -11.54 | -13.21 | -45.85 | Upgrade
|
| Interest & Investment Income | 0.15 | 0.15 | 0.12 | 0.62 | - | - | Upgrade
|
| Other Non Operating Income (Expenses) | 2.8 | 2.8 | 0 | 0 | - | 1.52 | Upgrade
|
| EBT Excluding Unusual Items | 2.26 | 2.26 | 7.76 | 8.34 | 9.38 | 7.82 | Upgrade
|
| Gain (Loss) on Sale of Assets | - | - | - | - | 0.3 | - | Upgrade
|
| Pretax Income | 2.26 | 2.26 | 7.76 | 8.34 | 9.68 | 7.82 | Upgrade
|
| Income Tax Expense | 0.67 | 0.67 | 2 | 2.25 | 3.86 | 3.51 | Upgrade
|
| Net Income | 1.58 | 1.58 | 5.76 | 6.09 | 5.82 | 4.31 | Upgrade
|
| Net Income to Common | 1.58 | 1.58 | 5.76 | 6.09 | 5.82 | 4.31 | Upgrade
|
| Net Income Growth | -68.15% | -72.49% | -5.38% | 4.55% | 35.10% | -41.88% | Upgrade
|
| Shares Outstanding (Basic) | 2 | 2 | 2 | 2 | 2 | 2 | Upgrade
|
| Shares Outstanding (Diluted) | 2 | 2 | 2 | 2 | 2 | 2 | Upgrade
|
| EPS (Basic) | 0.70 | 0.70 | 2.56 | 2.70 | 2.58 | 1.91 | Upgrade
|
| EPS (Diluted) | 0.70 | 0.70 | 2.56 | 2.70 | 2.58 | 1.91 | Upgrade
|
| EPS Growth | -68.15% | -72.49% | -5.38% | 4.55% | 35.10% | -41.88% | Upgrade
|
| Free Cash Flow | -5.24 | -5.24 | 0.31 | -13.13 | 59.85 | -77.72 | Upgrade
|
| Free Cash Flow Per Share | -2.33 | -2.33 | 0.14 | -5.83 | 26.57 | -34.50 | Upgrade
|
| Dividend Per Share | 0.333 | 0.333 | - | 1.667 | 1.389 | 1.111 | Upgrade
|
| Dividend Growth | -80.00% | - | - | 20.00% | 25.00% | 0% | Upgrade
|
| Gross Margin | 39.53% | 39.53% | 40.41% | 33.71% | 33.61% | 38.85% | Upgrade
|
| Operating Margin | 11.28% | 11.28% | 8.50% | 7.88% | 9.48% | 18.17% | Upgrade
|
| Profit Margin | 0.80% | 0.80% | 3.02% | 2.49% | 2.44% | 1.50% | Upgrade
|
| Free Cash Flow Margin | -2.66% | -2.66% | 0.16% | -5.38% | 25.13% | -27.08% | Upgrade
|
| EBITDA | 28.79 | 28.79 | 23.24 | 25.85 | 28.67 | 58.49 | Upgrade
|
| EBITDA Margin | 14.61% | 14.61% | 12.18% | 10.58% | 12.04% | 20.38% | Upgrade
|
| D&A For EBITDA | 6.57 | 6.57 | 7.02 | 6.6 | 6.08 | 6.35 | Upgrade
|
| EBIT | 22.22 | 22.22 | 16.22 | 19.25 | 22.59 | 52.14 | Upgrade
|
| EBIT Margin | 11.28% | 11.28% | 8.50% | 7.88% | 9.48% | 18.17% | Upgrade
|
| Effective Tax Rate | 29.86% | 29.86% | 25.78% | 27.01% | 39.87% | 44.87% | Upgrade
|
| Advertising Expenses | 2.2 | 2.2 | 3.19 | 3.51 | 2.38 | 2.72 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.